In Re Coordinated Pretrial Proceedings in Antibiotic Antitrust Actions

410 F. Supp. 706, 1975 U.S. Dist. LEXIS 11710
District Court, D. Minnesota·Decided June 25, 1975·No. 4-71 Civ. 435·Published·Cited by 12 cases

Opinion

MEMORANDUM OPINION APPROVING ALLOWANCE AND DISAL-LOWANCE OF CLAIMS, PLAN OF DISTRIBUTION AND AWARDING ATTORNEYS FEES

MILES W. LORD, District Judge.

This matter comes before the Court upon motion of the plaintiffs for an order approving a proposed plan of distribution and allowance and disallowance of claims in the above settled class actions. Also before the Court are nine applications for allowance of attorneys fees and costs.

The above actions were class actions brought by the Attorneys General of six States on behalf of their consumers. The cases were settled in 1973 and the processing of claims has continued since July of 1974. At this time, the Special Masters and the attorneys have recommended a plan of distribution and requested that the Court rule on the allowance and disallowance of claims. Pursuant to notice, a hearing was conducted before this Court on May 9, 1975 in regard to these matters. All States which were represented at the hearing and the informal conferences before the hearings have agreed to the proposed plan of distribution. All States have also agreed to the proposed allowance and disallowance of claims. No one appeared at the hearing to object to the proposed allowance of attorneys fees.

Under the present plan of distribution, approximately 980,000 consumers in the six states will be receiving refund checks. The Court notes the number of proposed recipients at the onset in order to familiarize the uninitiated with the tremendous magnitude and complexity of these settlements and the settlement administration.

*708 HISTORY OF THE CASE:

A thorough procedural and substantive history of these actions may be found in the Court’s Memorandum Approving Settlement, dated March 21, 1974. A very thorough procedural and substantive history of the case may also be found in the report of the Special Master, which is on file with the Court. Due to the interest which this plan of administration has generated, the Court has directed that the Special Master cause this report to be published.

These actions are a small part of the coordinated pre-trial proceedings in the In re Antibiotic Anti-Trust Actions, 4-71 Civ. 435 (D.Minn. filed August 1, 1971). In 1958 the Federal Trade Commission issued a complaint against American Cyanamid Co., Chas. Pfizer & Co., Inc., Bristol-Myers Company, Olin Mathieson Chemical Corporation and the Upjohn Company. The Commission’s proceedings continued until the mid 1960’s, at which time compulsory ■ licensing by Cyanamid and Pfizer was ordered.

In 1961 a criminal indictment was returned by the Federal Grand Jury of the Southern District of New York (61 Crim. 772) naming Cyanamid, Pfizer and Bristol and their chief executives as defendants; Squibb and Upjohn were named as co-conspirators. That indictment charged that the defendants, pursuant to a conspiracy, had misled the patent office in order to obtain a patent on tetracycline, and had used that patent to exclude competitors and to fix prices. All defendants pled not guilty. The criminal action was tried to a jury in November and December of 1968; the Honorable Marvin Frankel presiding. The jury returned a guilty verdict. The decision was appealed to the Court of Appeals for the 2nd Circuit. In April of 1970, that Court handed down its decision reversing the judgments of conviction and directing a new trial. U. S. v. Chas. Pfizer & Co., Inc., 426 F.2d 32 (2nd Cir., 1970). The United States Supreme Court affirmed the Court of Appeals for the 2nd Circuit and the criminal action was remanded for retrial. U. S. v. Chas. Pfizer & Co., Inc., 404 U.S. 548, 92 S.Ct. 731, 30 L.Ed.2d 721 (1971). Finally, on November 30, 1973, the Honorable John Cannella, Judge for the Southern District of' New York, sitting without a jury, returned a verdict finding the defendants not guilty on all counts of the indictment. Thus, after eleven years, the Federal criminal proceedings ended where they had begun.

Upon the return of the guilty verdict by the jury in 1968, several private, treble damage actions were filed. The 160 plaintiffs included Cities, Counties, States, Consumers, Insurance Companies, Agricultural Users, Hospitals, Blue Cross/Blue Shield, Union Health and Welfare Companies, Competitors and Foreign Governments. The cases were all transferred to the Honorable Inzer B. Wyatt of the Southern District of New York, pursuant to 28 U.S.C. § 1407 by the Judicial Panel on Multi-District Litigation.

On February 6, 1969 the defendants made a written global offer of $100,000,-000.00 in settlement of all claims of the fifty States, Counties, Cities and their political subdivisions and agencies and any other governmental entities, excluding the Federal government, arising out of their purchases or payments for broad spectrum antibiotics. This included the claims of the States as parens patriae on behalf of their citizens, or as class representatives on behalf of their consumers, including the State as a consumer and all other consumers in the States. This offer also included the claims of wholesalers, retailers and individual consumers arising out of such purchases. The settlement offer was accepted in principle by most of the States. The States of California, Kansas, Hawaii, Oregon, Utah and Washington as well as the State of North Carolina elected not to accept that offer. 1

*709 In June of 1970, Judge Wyatt approved the global settlement, adopting the so-called “Alabama plan” as the method for distributing that portion of the offered $100,000,000.00 going to plaintiffs accepting the offer. State of West Virginia v. Chas. Pfizer & Co., Inc., et al., 314 F.Supp. 710 (S.D.N.Y., 1970). Had the six States in these actions accepted that plan, they would have received the following amounts:

California, including Los ¡Angeles and San Francisco $10,511,500.00
Hawaii $ 267,300.00
Kansas $ 1,392,000.00
Oregon $ 791,000.00
Utah $ 339,300.00
Washington $ 1,549,900.00

These amounts were subject to a hold-back of twenty percent for both institutional and consumer purchases which was to be used as a reimbursement for any further, amounts that defendants might be required to pay to any Blue Cross Association or other insurer which may have indemnified the settling entity with respect to a portion of the payment so allocated.

The amounts which were finally deposited for the benefit of the consumers for these six States, including Welfare and the County of Los Angeles and City and County of San Francisco, pursuant to the terms of this settlement are as follows:

California $28,140,000.00
Hawaii $ 351,000.00
Kansas $ 3,570,000.00

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Coordinated Pretrial Proceedings in Antibiotic Antitrust Actions, 410 F. Supp. 706, 1975 U.S. Dist. LEXIS 11710 (mnd 1975).

410 F. Supp. 706 (In Re Coordinated Pretrial Proceedings in Antibiotic Antitrust Actions) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In re Lease Oil Antitrust Litigation
186 F.R.D. 403 (S.D. Texas, 1999)
State of California v. Levi Strauss & Co.
715 P.2d 564 (California Supreme Court, 1986)
Muehler v. Land O'Lakes, Inc.
617 F. Supp. 1370 (D. Minnesota, 1985)
In re Fine Paper Antitrust Litigation
98 F.R.D. 48 (E.D. Pennsylvania, 1983)
In Re Coordinated Pretrial Proceedings, Etc.
520 F. Supp. 635 (D. Minnesota, 1981)
International Rectifier Corp. v. American Cyanamid Co.
520 F. Supp. 635 (D. Minnesota, 1981)
Oswald v. General Motors Corp.
594 F.2d 1106 (Seventh Circuit, 1979)